By quantitatively analyzing over 1,800 key immuno-oncology-related genes in a spatially directed manner, a deep tumor-immune profile was established within the tumor (PanCK +) and stromal (CD45 +) regions (Fig. 1D). This evidence concerns the gene PTPRC and neoplasm.